Ovarian Blockade During Fertility Preservation in Patients With Endometriosis - Trial NCT06106919
Access comprehensive clinical trial information for NCT06106919 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de Nฤซmes and is currently Not yet recruiting. The study focuses on Endometriosis. Target enrollment is 300 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Centre Hospitalier Universitaire de Nฤซmes
Timeline & Enrollment
N/A
Dec 01, 2023
Dec 31, 2025
Primary Outcome
Number of mature oocytes collected by ovarian puncture
Summary
The aim of the study is to demonstrate the non-inferiority of dienogest on the number of
 mature oocytes collected compared with conventional ovarian stimulation protocols (using a
 GnRH agonist or antagonist), in patients with endometriosis in a fertility preservation
 context.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06106919
Non-Device Trial